Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that Mark L. Baum, Chief Executive Officer, and Andrew Boll, Chief Financial Officer, will participate in the following two upcoming conferences:

BTIG 3rd Annual Ophthalmology Day Format: Fireside Chat (Virtual) Date/Time: Monday, November 27, 2023, at 1:30 p.m. ET

Piper Sandler 35th Annual Healthcare Conference (The Lotte New York Palace, New York, NY) Format: Fireside Chat (In-Person) Date/Time: Thursday, November 30, 2023, at 8:00 a.m. ET

Harrow management will be available for one-on-one meetings during both conferences. Investors interested in meeting with management should contact their BTIG or Piper Sandler representative to request a meeting.

About Harrow

Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the U.S. market. Harrow helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans each year. For more information about Harrow, please visit harrow.com.

Jamie Webb, Director of Communications and Investor Relations jwebb@harrowinc.com 615-733-4737

Grafico Azioni Harrow (NASDAQ:HROW)
Storico
Da Apr 2024 a Mag 2024 Clicca qui per i Grafici di Harrow
Grafico Azioni Harrow (NASDAQ:HROW)
Storico
Da Mag 2023 a Mag 2024 Clicca qui per i Grafici di Harrow